Research ArticleAutism Spectrum Disorder
A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism
- Karen J. Parker1,*,
- Ozge Oztan1,
- Robin A. Libove1,
- Noreen Mohsin1,
- Debra S. Karhson1,
- Raena D. Sumiyoshi1,
- Jacqueline E. Summers1,
- Kyle E. Hinman1,
- Kara S. Motonaga2,
- Jennifer M. Phillips1,
- Dean S. Carson1,
- Lawrence K. Fung1,
- Joseph P. Garner1,3 and
- Antonio Y. Hardan1
- 1Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305, USA.
- 2Department of Pediatrics, Stanford University, Stanford, CA 94305, USA.
- 3Department of Comparative Medicine, Stanford University, Stanford, CA 94305, USA.
- ↵*Corresponding author. Email: kjparker{at}stanford.edu
See allHide authors and affiliations
Science Translational Medicine 08 May 2019:
Vol. 11, Issue 491, eaau7356
DOI: 10.1126/scitranslmed.aau7356
